Copyright Reports & Markets. All rights reserved.

Global and Japan Long-Acting Injectables Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Long-Acting Injectables Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Small and Middle Sized Molecule
    • 1.2.3 Large Sized Molecule
  • 1.3 Market by Application
    • 1.3.1 Global Long-Acting Injectables Market Share by Application: 2020 VS 2026
    • 1.3.2 Schizophrenia
    • 1.3.3 Other Psychotic Disorders
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Long-Acting Injectables Market Perspective (2015-2026)
  • 2.2 Global Long-Acting Injectables Growth Trends by Regions
    • 2.2.1 Long-Acting Injectables Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Long-Acting Injectables Historic Market Share by Regions (2015-2020)
    • 2.2.3 Long-Acting Injectables Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Long-Acting Injectables Players by Market Size
    • 3.1.1 Global Top Long-Acting Injectables Players by Revenue (2015-2020)
    • 3.1.2 Global Long-Acting Injectables Revenue Market Share by Players (2015-2020)
  • 3.2 Global Long-Acting Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Long-Acting Injectables Revenue
  • 3.4 Global Long-Acting Injectables Market Concentration Ratio
    • 3.4.1 Global Long-Acting Injectables Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Long-Acting Injectables Revenue in 2019
  • 3.5 Key Players Long-Acting Injectables Area Served
  • 3.6 Key Players Long-Acting Injectables Product Solution and Service
  • 3.7 Date of Enter into Long-Acting Injectables Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Long-Acting Injectables Breakdown Data by Type (2015-2026)

  • 4.1 Global Long-Acting Injectables Historic Market Size by Type (2015-2020)
  • 4.2 Global Long-Acting Injectables Forecasted Market Size by Type (2021-2026)

5 Long-Acting Injectables Breakdown Data by Application (2015-2026)

  • 5.1 Global Long-Acting Injectables Historic Market Size by Application (2015-2020)
  • 5.2 Global Long-Acting Injectables Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Long-Acting Injectables Market Size (2015-2026)
  • 6.2 North America Long-Acting Injectables Market Size by Type (2015-2020)
  • 6.3 North America Long-Acting Injectables Market Size by Application (2015-2020)
  • 6.4 North America Long-Acting Injectables Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Long-Acting Injectables Market Size (2015-2026)
  • 7.2 Europe Long-Acting Injectables Market Size by Type (2015-2020)
  • 7.3 Europe Long-Acting Injectables Market Size by Application (2015-2020)
  • 7.4 Europe Long-Acting Injectables Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Long-Acting Injectables Market Size (2015-2026)
  • 8.2 China Long-Acting Injectables Market Size by Type (2015-2020)
  • 8.3 China Long-Acting Injectables Market Size by Application (2015-2020)
  • 8.4 China Long-Acting Injectables Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Long-Acting Injectables Market Size (2015-2026)
  • 9.2 Japan Long-Acting Injectables Market Size by Type (2015-2020)
  • 9.3 Japan Long-Acting Injectables Market Size by Application (2015-2020)
  • 9.4 Japan Long-Acting Injectables Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Long-Acting Injectables Market Size (2015-2026)
  • 10.2 Southeast Asia Long-Acting Injectables Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Long-Acting Injectables Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Long-Acting Injectables Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Eli Lilly
    • 11.1.1 Eli Lilly Company Details
    • 11.1.2 Eli Lilly Business Overview
    • 11.1.3 Eli Lilly Long-Acting Injectables Introduction
    • 11.1.4 Eli Lilly Revenue in Long-Acting Injectables Business (2015-2020))
    • 11.1.5 Eli Lilly Recent Development
  • 11.2 Pfizer
    • 11.2.1 Pfizer Company Details
    • 11.2.2 Pfizer Business Overview
    • 11.2.3 Pfizer Long-Acting Injectables Introduction
    • 11.2.4 Pfizer Revenue in Long-Acting Injectables Business (2015-2020)
    • 11.2.5 Pfizer Recent Development
  • 11.3 GlaxoSmithKline
    • 11.3.1 GlaxoSmithKline Company Details
    • 11.3.2 GlaxoSmithKline Business Overview
    • 11.3.3 GlaxoSmithKline Long-Acting Injectables Introduction
    • 11.3.4 GlaxoSmithKline Revenue in Long-Acting Injectables Business (2015-2020)
    • 11.3.5 GlaxoSmithKline Recent Development
  • 11.4 Johnson & Johnson
    • 11.4.1 Johnson & Johnson Company Details
    • 11.4.2 Johnson & Johnson Business Overview
    • 11.4.3 Johnson & Johnson Long-Acting Injectables Introduction
    • 11.4.4 Johnson & Johnson Revenue in Long-Acting Injectables Business (2015-2020)
    • 11.4.5 Johnson & Johnson Recent Development
  • 11.5 Lupin Limited
    • 11.5.1 Lupin Limited Company Details
    • 11.5.2 Lupin Limited Business Overview
    • 11.5.3 Lupin Limited Long-Acting Injectables Introduction
    • 11.5.4 Lupin Limited Revenue in Long-Acting Injectables Business (2015-2020)
    • 11.5.5 Lupin Limited Recent Development
  • 11.6 Zogenix
    • 11.6.1 Zogenix Company Details
    • 11.6.2 Zogenix Business Overview
    • 11.6.3 Zogenix Long-Acting Injectables Introduction
    • 11.6.4 Zogenix Revenue in Long-Acting Injectables Business (2015-2020)
    • 11.6.5 Zogenix Recent Development
  • 11.7 DURECT
    • 11.7.1 DURECT Company Details
    • 11.7.2 DURECT Business Overview
    • 11.7.3 DURECT Long-Acting Injectables Introduction
    • 11.7.4 DURECT Revenue in Long-Acting Injectables Business (2015-2020)
    • 11.7.5 DURECT Recent Development
  • 11.8 Medincel
    • 11.8.1 Medincel Company Details
    • 11.8.2 Medincel Business Overview
    • 11.8.3 Medincel Long-Acting Injectables Introduction
    • 11.8.4 Medincel Revenue in Long-Acting Injectables Business (2015-2020)
    • 11.8.5 Medincel Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Long-Acting Injectables Scope and Market Size
    Long-Acting Injectables market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Long-Acting Injectables market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Small and Middle Sized Molecule
    Large Sized Molecule

    Market segment by Application, split into
    Schizophrenia
    Other Psychotic Disorders

    Based on regional and country-level analysis, the Long-Acting Injectables market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Long-Acting Injectables market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Eli Lilly
    Pfizer
    GlaxoSmithKline
    Johnson & Johnson
    Lupin Limited
    Zogenix
    DURECT
    Medincel

    Buy now